Over the past decade, the global scientific community have begun to recognize the unmatched value of an extraordinary drug, ivermectin, that originates from a single microbe unearthed from soil in Japan. Work on ivermectin has seen its discoverer, Satoshi Ōmura, of Tokyo’s prestigious Kitasato Institute, receive the 2014 Gairdner Global Health Award and the 2015 Nobel Prize in Physiology or Medicine, which he shared with a collaborating partner in the discovery and development of the drug, William Campbell of Merck & Co. Incorporated. Today, ivermectin is continuing to surprise and excite scientists, offering more and more promise to help improve global public health by treating a diverse range of diseases, with its unexpected potential as an antibacterial, antiviral and anti-cancer agent being particularly extraordinary.
Supreme Court to determine appeal relating to a one-legged man’s right to live on his yacht after discharge from Royal Hobart hospital
- Details
-
Category: Australian public guardian corruption
-
Created: Tuesday, 19 November 2019 23:38
-
Written by Loretta Lohberger - Daily Mercury
The man at the centre of a legal battle over his right to live on a yacht after his discharge from hospital has died but the case continues in the Supreme Court.
THE Supreme Court will determine an appeal relating to a one-legged man’s right to live on his yacht, despite the man’s recent death.
- Abuser Name or Alias::
Paul Turner, SC
- Abusers Organisation::
Tasmanian Health Service has appealed against a Supreme Court decision to set aside a guardianship order that could have stopped the mature-aged, one-legged man from living aboard his yacht for six months after he was discharged from the Royal Hobart Hospital.
- Type of Abuse::
Financial, Physical, Neglect, Emotional, Psychological or Mental, Death
- Matter Resolved?:
Ongoing